Licorice and cancer

Nutrition and Cancer

Volumn 39, Issue 1, 2001, Pages 1-11

  Wang, Z Y ^a   Nixon, D W ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCYRRHETINIC ACID; POLYPHENOL; SWEETENING AGENT; TRITERPENOID;

BIOTRANSFORMATION; CANCER; CANCER INHIBITION; CANCER PREVENTION; CHINESE MEDICINE; DNA DAMAGE; DRUG EFFICACY; DRUG METABOLISM; DRUG POTENCY; GLYCYRRHIZA; NONHUMAN; NUTRITION; RECEPTOR DOWN REGULATION; REVIEW;

GLYCYRRHIZA;

EID: 0034819068     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914nc391_1     Document Type: Review

References (118)

1. Glycyrrhiza plants
2. Glycyrrhiza in old and new perspectives
3. Liquorice Glycyrrhiza glabra L.: Composition, uses and analysis
4. Phenolic constituents of licorice (Glycyrrhiza species)
5. A drug over the millennia: Pharmacognosy, chemistry, and pharmacology of licorice
6. GRAS status of licorice (Glycyrrhiza), ammoniated glycyrrhizin, and monoammonium glycyrrhizinate
7. The determination of glycyrrhizin in selected UK liquorice products
8. Liquorice consumption and its influence on blood pressure in Danish school children
9. Drugs used in gastrointestinal diseases
10. The importance of pharmacokinetic and receptor studies in drug safety evaluation
11. Prevention of cancer chemotherapeutic agent-induced toxicity in post-operative breast cancer patients with glycyrrhizin (SNMC)
12. Variation of chemical constituents in processed licorice roots: Quantitative determination of saponin and flavonoid constituents in bark-removed and roasted licorice roots
13. Inhibition of mouse skin tumor-initiating activity of DMBA by chronic oral feeding of glycyrrhizin in drinking water
14. Licorice inhibits corticosteroid 11β-dehydrogenase of rat kidney and liver: In vivo and in vitro studies
15. Licorice and enzymes other than 11β-hydroxysteroid dehydrogenase: An evolutionary perspective
16. Inhibition of 11βhydroxysteroid dehydrogenase obtained from guinea pig kidney by furosemide, naringenin and some other compounds
17. Endocrine activity of plant-derived compounds: An evolutionary perspective
18. In vivo and in vitro effects of carbenoxolone on glucocorticoid receptor binding and glucocorticoid activity
19. Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors
20. The pathogenesis of pseudohyperaldosteronism from carbenoxolone
21. Glycyrrhizin improves the resistance of MAIDS mice to opportunistic infection of Candida albicans through the modulation of MAIDS-associated types 2 T cell responses
22. Protective effects of Glycyrrhizae radix extract and its compounds in a renal hypoxia (ischemia)-reoxygenation (reperfusion) model
23. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection
24. Sweetening agents from natural sources
25. HPLC analysis of flavonoids in the root of six Glycyrrhiza species
26. Effects of baicalin and liquid extract of licorice on sorbitol level in red blood cells of diabetic rats
27. 13C-NMR to structural identification of the flavonoid glycosides
28. Inhibition of adenosine 3′,5′-cyclic monophosphate phosphodiesterase by flavonoids from licorice roots and 4-arylcoumarins
29. +
30. Glycosides of phenolic acid and flavonoids from the leaves of Glycyrrhiza uralensis Ficsh
31. Two new isoprenyl flavonoids from the leaves of Glycyrrhiza uralensis Fisch
32. Grapefruit juice and its flavonoids inhibit 11β-hydroxysteroid dehydrogenase
33. Antioxidant constituents from licorice roots: Isolation, structure elucidation and antioxidative capacity toward LDL oxidation
34. Phenolic constituents of licorice. VIII. Structures of glicophenone and glicoisoflavanone and effects of licorice phenolics on methicillin-resistant Staphylococcus aureus
35. 7-Hydroxy-4′-methoxy-isoflavone (formononetin) from liquorice root. On substances contained in liquorice root. II
36. Studies on chemical constituents of Glycyrrhiza eurycarpa P. C. Li
37. Four new phenolic constituents from licorice (root of Glycyrrhiza sp.)
38. Phenolic constituents of licorice. IV. Correlation of phenolic constituents and licorice specimens from various sources and inhibitory effects of licorice extracts on xanthine oxidase and monoamine oxidase
39. Phenolic constituents of licorice. III. Structures of glicoricone and licofuranone, and inhibitory effects of licorice constituents on monoamine oxidase
40. Chemical studies of Chinese licorice-roots. I. Elucidation of five new flavonoid constituents from the roots of Glycyrrhiza glabra L. collected in Xinjiang
41. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation
42. Structural aspects of the inhibitory effect of glabridin on LDL oxidation
43. Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata
44. Protection of mitochondrial functions against oxidative stresses by isoflavans from Glycyrrhiza glabra
45. Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell-mediated oxidation of low-density lipoprotein. A possible role for protein kinase C
46. Immunopotentiating effect of traditional Chinese drugs-ginsenoside and glycyrrhiza polysaccharide
47. Characterization of two polysaccharides having activity on the reticuloendothelial system from the root of Glycyrrhiza uralensis
48. A novel neutral polysaccharide having activity on the reticuloendothelial system from the root of Glycyrrhiza uralensis
49. Heterogeneity and characterisation of mitogenic and anti-complementary pectic polysaccharides from the roots of Glycyrrhiza uralensis Fisch et D.C.
50. The core structure and immunological activities of glycyrrhizan UA, the main polysaccharide from the root of Glycyrrhiza uralensis
51. Inhibition of mutagenicity in Salmonella typhimurium and skin tumor initiating and tumor promoting activities in SENCAR mice by glycyrrhetinic acid: Comparison of 18α- and 18β-stereoisomers
52. Blockage of Glycyrrhiza uralensis and Chelidonium majus in MNNG-induced cancer and mutagenesis
53. Antimutagenicity screening of water extracts from 102 kinds of Chinese medicinal herbs
54. Studies on modifiers of microsomal drug oxidation
55. Antioxidative properties of glycyrrhyzic acid salts and their effect on the liver monooxygenase system
56. 1 by licorice compounds
57. Anti-promoting and anti-mutagenic actions of G9315
58. Tumorigenicity study of disodium glycyrrhizinate administered orally to mice
59. Glycyrrhetic acid inhibits tumor-promoting activity of teleocidin and 12-O-tatradecanoylphorbol-13-acetate in two-stage mouse skin carcinogenesis
60. Inhibition of the tumor-promoting action of 12-O-tetradecanoylphorbol-13-acetate by some oleanane-type triterpenoid compounds
61. Inhibitory effect of glycyrrhizin and caffeine on two-stage carcinogenesis in mice
62. Protection against benzo[a]pyrene- and N-nitrosodiethylamine-induced lung and forestomach tumorigenesis in A/J mice by water extracts of green tea and licorice
63. The long-term efficacy of glycyrrhizin in chronic hepatitis C patients
64. Ultrastructural studies on the protective effect of glycyrrhizin for liver injury induced by a carcinogen (3′-Me-DAB) (the second report)
65. Antitumor-promoting activity of glycyrrhetinic acid and its related compounds
66. Clinical development plan: 18β-glycyrrhetinic acid
67. Inhibition of 11β-hydroxysteroid dehydrogenase activity enhances the antiproliferative effect of glucocorticosteroids on MCF-7 and ZR-75-1 breast cancer cells
68. Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid
69. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cell
70. Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots
71. State of pulmonary metabolism during radiotherapy of thoracic neoformations and possibilities of its correction
72. Inhibition of benzo[a]pyrene- and 1,6-dinitropyrene-DNA adduct formation in human mammary epithelial cells by dibenzoylmethane and sulforaphane
73. Inhibition of the specific binding of 12-O-tetradecanoylphorbol-13-acetate to mouse epidermal membrane fractions by glycyrrhetic acid
74. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis by sweetening agents and related compounds
75. Inhibition of protein kinase C by the 12-O-tetradecanoylphorbol-13-acetate antagonist glycyrrhetic acid
76. Anti-tumorigenic chalcones
77. Estrogen and progestin bioactivity of foods, herbs, and spices
78. Prevention of breast cancer
79. The anti-estrogenic action of β-glycyrrhetinic acid
80. Effect of glycyrrhizin on estrogen action
81. Inhibition by plant herb extracts of steroid bindings in uterus, liver and serum of the rabbit
82. Structure and mechanism of action and inhibition of steroid dehydrogenase enzymes involved in hypertension
83. Teratogenicity study of ammonium glycyrrhizinate in the Sprague-Dawley rat
84. Toxicological assessment of liquorice: Biliary excretion in rats
85. Liquorice and its health implications
86. Licorice-induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity
87. Cardiac arrest due to liquorice-induced hypokalaemia
88. Effect of eating liquorice on the renin-angiotensin-aldosterone axis in normal subjects
89. Liquorice toxicity and the renin-angiotensin-aldosterone axis in man
90. Hyperprolactinaemia and liquorice
91. Tobacco chewer's hypokalemia: Licorice revisited
92. Liquorice can damage your health
93. Glycyrrhizic acid in liquorice - Evaluation of health hazard
94. Phase I pharmacology and toxicity study of glycyrrhetinic acid as a chemopreventive drug
95. Low doses of liquorice can induce hypertension encephalopathy
96. Intestinal bacterial hydrolysis is indispensable to absorption of 18β-glycyrrhetic acid after oral administration of glycyrrhizin in rats
97. Hydrolysis of glycyrrhetyl mono-glucuronide to glycyrrhetic acid by glycyrrhetyl mono-glucuronide β-D-glucuronidase of Eubacterium sp. GLH
98. Biotransformation of glycyrrhizin to 18-β-glycyrrhetinic acid-3-O-β-D-glucuronide by Streptococcus LJ-22, a human intestinal bacterium
99. Scientific reevaluation of Kampo prescriptions using modern technology
100. Glycyrrhetic acid in human blood after ingestion of glycyrrhizic acid in licorice
101. Metabolism of glycyrrhetic acid by rat liver microsomes. II. 22-α- and 24-hydroxylation
102. Localization of enzymes involved in metabolism of glycyrrhizin in contents of rat gastrointestinal tract
103. Dose-dependent pharmacokinetics of glycyrrhizin in rats
104. Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats: Relevance to the intestinal bacterial hydrolysis
105. Pharmacokinetics of glycyrrhizin in rats with D-galactosamine-induced hepatic disease
106. Disposition of glycyrrhizin in the perfused liver of rats
107. Kinetic analysis of glycyrrhetic acid, an active metabolite of glycyrrhizin, in rats: Role of enterohepatic circulation
108. Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C
109. HPLC determination of glycyrrhizin and glycyrrhetic acid in biological fluids, after licorice extract administration to humans and rats
110. Bioavailability of glycyrrhizin and licorice extract in rat and human plasma as detected by a HPLC method
111. The choleretic effects of licorice: Identification and determination of the pharmacologically active components of Glycyrrhiza glabra
112. Interaction of licorice on glycyrrhizin pharmacokinetics
113. Prevention of cancer in the next millennium: Report of the chemoprevention working group to the American Association for Cancer Research